Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2021 5
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma.
Tannir NM, Signoretti S, Choueiri TK, McDermott DF, Motzer RJ, Flaifel A, Pignon JC, Ficial M, Frontera OA, George S, Powles T, Donskov F, Harrison MR, Barthélémy P, Tykodi SS, Kocsis J, Ravaud A, Rodriguez-Cid JR, Pal SK, Murad AM, Ishii Y, Saggi SS, McHenry MB, Rini BI. Tannir NM, et al. Among authors: rodriguez cid jr. Clin Cancer Res. 2021 Jan 1;27(1):78-86. doi: 10.1158/1078-0432.CCR-20-2063. Epub 2020 Sep 1. Clin Cancer Res. 2021. PMID: 32873572 Free PMC article.
Survival prognostic factors in unresectable/advanced primary thoracic sarcomas.
Rodriguez-Cid JR, Juarez-Vignon Whaley JJ, Sánchez-Domínguez G, Guzmán-Casta J, Carrasco-CaraChards S, Alatorre-Alexander JA, Martínez-Barrera LM, Sánchez-Rios CP, Flores-Mariñelarena RR, Seidman-Sorsby A, Cruz-Zermeño M, Rodríguez-Zea IJ, Santillan-Doherty PJ. Rodriguez-Cid JR, et al. J Thorac Dis. 2022 Sep;14(9):3376-3385. doi: 10.21037/jtd-22-472. J Thorac Dis. 2022. PMID: 36245612 Free PMC article.
Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas.
Rodriguez-Cid JR, Juarez-Vignon Whaley JJ, Sánchez-Domínguez G, Guzmán-Casta J, Carrasco-CaraChards S, Guzmán-Huesca J, Riera-Sala R, Sánchez-Ríos CP, Cruz-Zermeño M, Seidman-Sorsby A, de Jesús Rodríguez-Zea I, Alatorre-Alexander JA, Martínez-Barrera LM, Santillán-Doherty PJ, Godina-Flores A, Imaz-Olguin V, Sosa-Sánchez R, Green-Renner D. Rodriguez-Cid JR, et al. J Cancer Res Clin Oncol. 2023 Aug;149(9):5479-5491. doi: 10.1007/s00432-022-04454-8. Epub 2022 Dec 4. J Cancer Res Clin Oncol. 2023. PMID: 36463530
Prognostic factors for progression-free and overall survival in malignant pleural mesothelioma.
Guzmán-Casta J, Carrasco-CaraChards S, Guzmán-Huesca J, Sánchez-Ríos CP, Riera-Sala R, Martínez-Herrera JF, Peña-Mirabal ES, Bonilla-Molina D, Alatorre-Alexander JA, Martínez-Barrera LM, Rodríguez-Cid JR. Guzmán-Casta J, et al. Among authors: rodriguez cid jr. Thorac Cancer. 2021 Apr;12(7):1014-1022. doi: 10.1111/1759-7714.13814. Epub 2021 Mar 4. Thorac Cancer. 2021. PMID: 33660947 Free PMC article.
A comparative study of immunotherapy as second-line treatment and beyond in patients with advanced non-small-cell lung carcinoma.
Rodríguez-Cid JR, Chards SC, González-Espinoza IR, García-Montes V, Garibay-Díaz JC, Hernández-Flores O, Riera-Sala R, Gozalishvili-Boncheva A, Alatorre-Alexander JA, Martínez-Barrera LM, Sánchez-Ríos CP, Martinez-Camacho A, Martínez-Herrera JF, Guzmán-Casta J, Flores-Mariñelarena RR, Diaz-Rico J, Santillán-Doherty P. Rodríguez-Cid JR, et al. Lung Cancer Manag. 2021 Mar 11;10(3):LMT47. doi: 10.2217/lmt-2020-0027. eCollection 2021 Sep. Lung Cancer Manag. 2021. PMID: 34408789 Free PMC article.
Expression of estrogen receptor beta (ERβ) and its prognostic value in pleural mesothelioma.
Rodríguez-Cid JR, García-Acevedo O, Benjamin-Contreras J, Bonilla-Molina D, Flores-Mariñelarena RR, Martínez-Barrera L, Alatorre-Alexander JA, Sanchez-Ríos CP, Flores-Soto MDR, Santillan-Doherty PJ, Peña-Mirabal ES. Rodríguez-Cid JR, et al. J Thorac Dis. 2019 Apr;11(4):1456-1464. doi: 10.21037/jtd.2019.03.38. J Thorac Dis. 2019. PMID: 31179088 Free PMC article.
Human skin biomarkers relationship to response to treatment with tyrosine kinase inhibitors in advanced EGFR-mutated lung adenocarcinoma.
Castañeda-Zárraga A, Rodríguez-Cid JR, Flores-Mariñelarena RR, Trinidad-Bibiano H, Martínez-Herrera JF, Sánchez-Ríos CP, Fernández-Garibay VM, Alatorre-Alexander JA, Martínez-Barrera L, Santillán-Doherty PJ, Vega-Memije ME. Castañeda-Zárraga A, et al. Among authors: rodriguez cid jr. Thorac Cancer. 2020 Nov;11(11):3243-3251. doi: 10.1111/1759-7714.13657. Epub 2020 Oct 5. Thorac Cancer. 2020. PMID: 33015988 Free PMC article.
Paraneoplastic Cerebellar Degeneration with Anti-CV2/CRMP5 Antibodies in Ovarian Cancer: Case Report and Review of the Literature.
Juárez-Vignon Whaley JJ, Carrera-Muiños A, Hernandez-Gutierrez KG, Rodriguez-Cid JR, Otero-Cerdeira ME, Garcia-Montes V. Juárez-Vignon Whaley JJ, et al. Among authors: rodriguez cid jr. Case Rep Oncol. 2021 Dec 20;14(3):1799-1805. doi: 10.1159/000519969. eCollection 2021 Sep-Dec. Case Rep Oncol. 2021. PMID: 35111012 Free PMC article.
Myoepithelial Carcinoma Arising in a Plasmacytoid Myoepithelioma of the Parotid Gland Synchronized with Melanoma: A Case Report and Review of the Literature.
Soberanis-Piña PD, Fernández-Ferreira R, Buerba-Vieregge HH, Varela-Santoyo E, Rodriguez-Cid JR, Macari-Jorge A, Dorantes-Heredia R. Soberanis-Piña PD, et al. Among authors: rodriguez cid jr. Case Rep Oncol. 2021 Mar 1;14(1):173-183. doi: 10.1159/000510937. eCollection 2021 Jan-Apr. Case Rep Oncol. 2021. PMID: 33776700 Free PMC article.
12 results